Drug intelligence / Profile preview

goose parvovirus inactivated vaccine (TZ10 strain)

Development stage
Unknown
Lead developer
Youbang Pharmaceutical
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

The goose parvovirus inactivated vaccine (TZ10 strain) is a veterinary vaccine developed by Youbang Pharmaceutical (Yangzhou Youbang Biopharmaceuticals Co., Ltd.) to protect against goose parvovirus (GPV), the causative agent of gosling plague, also known as Derzsy's disease. This inactivated vaccine utilizes the TZ10 strain of the virus to stimulate the immune system of geese and goslings, inducing protective antibodies without causing active infection. Gosling plague is a highly contagious and often fatal disease, particularly in young birds under 4 weeks of age. The vaccine is approved for use in China and is part of Youbang Pharmaceutical's waterfowl vaccine portfolio.

Other names
小鹅瘟灭活疫苗Gosling plague inactivated vaccineGoose parvovirus inactivated vaccineDerzsy's disease vaccine
02

Targets

GPV (Goose parvovirus)

Beyond the preview

Go deeper on goose parvovirus inactivated vaccine (TZ10 strain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on goose parvovirus inactivated vaccine (TZ10 strain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call